新兴的治疗方法用于治疗肠道纤维化和狭窄
Yub Raj Neupane1, Thanuja Marasarakottige Yogananda1, Sri Vishnu Kiran Rompicharla1
1Center for Nanomedicine at the Wilmer Eye Institute, The Johns Hopkins University School of Medicine, Baltimore, MD, United States; Department of Ophthalmology, The Johns Hopkins University School of Medicine, Baltimore, MD, United States.
针对炎症性肠道疾病 (IBD) 患者,需要针对肠道纤维化的新疗法. 新兴的疗法和药物输送系统为管理纤维化狭窄和预防复发提供了希望.
科学领域:
- 胃肠病学 胃肠病学
- 纤维化研究 纤维化研究
- 药物输送系统 药物输送系统
背景情况:
- 在炎症性肠病 (IBD) 中,慢性肠炎可以导致纤维化和狭窄.
- 目前的治疗方法,如气球扩张和手术都有局限性,包括并发症和高复发率.
- 现有的抗炎疗法对IBD中纤维化进展和狭窄复发的疗效有限.
研究的目的:
- 审查肠道纤维化和IBD狭窄的新兴治疗策略.
- 突出用于管理纤维化并发症的新型药物输送系统.
- 解决急需针对IBD的创新纤维化向治疗的迫切需要.
主要方法:
- 对肠道纤维化新兴治疗方法的文献综述.
- 对IBD中纤维性狭窄的当前治疗限制的分析.
- 在临床前和临床研究中探索新型药物输送系统.
主要成果:
- 目前的IBD治疗方法不足以有效管理纤维化和收缩.
- 新兴疗法在向纤维化过程方面表现有前途.
- 新的药物输送系统可以提高治疗效率并减少复发.
结论:
- 针对纤维化的创新治疗方法对于IBD管理至关重要.
- 新兴药物和先进的输送系统代表了一个有希望的前沿.
- 需要进一步的研究来将这些创新转化为IBD患者的临床实践.
相关概念视频
Inflammatory Bowel Disease V: Surgical Management
Here are some common surgical interventions for IBD:
Inflammatory Bowel Disease IV: Pharmacological Management
Pharmacologic...
Drugs for Treatment of Constipation-Predominant IBS
Drugs for Treatment of Diarrhea-Predominant IBS
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Drugs for Treatment of Ulcerative Colitis in IBD


